Published in Women's Health Weekly, July 10th, 2003
According to published research from Germany, "A recent editorial in the prestigious New England Journal of Medicine was entitled, 'The beginning of the end of cervical cancer'' It was a comment on the promising phase 11 study results of a preventive vaccine against human pathogenic papilloma virus (HPV) 16."
"Based on a large body of experimental and epidemiological evidence, the causative role of HPVs in the development of cervical cancer is well established," commented Thomas A. Grubert and K. Friese at Ludwig-Maximilians-University of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly